Armata Pharmaceuticals Inc. Gains 31.15%

Armata Pharmaceuticals Inc. (ARMP:NYSEMKT) rocketted at $4.21, a gain of 31.2%. On Fri, Sep 16, 2022, ARMP:NYSEMKT touched a New 2-Week High of $4.21. From Fri, Sep 02, 2022, the stock recorded 33.33% Up Days and 30.00% Green Days

About Armata Pharmaceuticals Inc. (ARMP:NYSEMKT)

Ampliphi Biosciences Corp is a clinical-stage biotechnology company focused on the development of bacteriophage-based therapies for the treatment of antibiotic-resistant bacterial infections. The company is developing phage product candidates using a proprietary discovery and development platform, which is designed for rapid identification, characterization, and manufacturing of multiple phage therapeutics. The lead product candidates are AB-SA01 for the treatment of Staphylococcus aureus infections; and AB-PA01 for the treatment of Paeruginosa infections.